Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
53°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
776.75
-4.35 (-0.56%)
Official Closing Price
Updated: 7:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
76
77
Next >
Dow Falls Over 100 Points; McCormick Sales Miss Views
October 03, 2023
U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.37% to 33,310.99 while the NASDAQ fell...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Point Biopharma Stock Launches 84% On Eli Lilly's $1.4 Billion Takeover
October 03, 2023
The company is working on targeted radiation therapy with prostate cancer results up next.
Via
Investor's Business Daily
Why Is Cancer Treatment Focused POINT Biopharma Stock Trading Higher Today?
October 03, 2023
Eli Lilly And Co (NYSE: LLY) agreed to acquire POINT Biopharma Global Inc (NASDAQ: PNT) at $12.50 per share in cash, an aggregate of
Via
Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
October 03, 2023
ALX Oncology Holdings Inc (NASDAQ: ALXO) released prespecified interim Phase 2 data from its ASPEN-06 trial of evorpacept plus trastuzumab, Cyramza (ramucirumab) and paclitaxel for HER2-positive...
Via
Benzinga
Why Is Point Biopharma (PNT) Stock Up 84% Today?
October 03, 2023
Point Biopharma stock is heading higher on Tuesday as investors react to news of Eli Lilly acquiring the shares of PNT for $12.50 each.
Via
InvestorPlace
Analyst Ratings for Eli Lilly
October 02, 2023
Via
Benzinga
FDA Declines To Approve Eli Lilly's Eczema Drug
October 02, 2023
The U.S.
Via
Benzinga
Exposures
Product Safety
Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%
October 03, 2023
Soleno Therapeutics is working on a treatment for Prader Willi syndrome, a genetic disease that causes obesity.
Via
Investor's Business Daily
Why Shares of Structure Therapeutics Are Up Monday
October 02, 2023
The stock climbed for the second straight day after the company reported positive trial data for its weight-loss therapy drug.
Via
The Motley Fool
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
October 02, 2023
The stars are aligning for these pharmaceutical giants, making their stocks look ready to run higher in next year.
Via
InvestorPlace
Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns
October 02, 2023
These biotech stocks, Thermo Fisher, Novo Nordisk, and Eli Lilly, will bring consistent returns in the volatile biotech sector.
Via
InvestorPlace
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
October 01, 2023
These defensive index funds can help investors hedge against a possible recession.
Via
The Motley Fool
What A Government Shutdown Could Mean For You
September 30, 2023
In a nail-biting development amid fears of a government shutdown, the House has passed a bipartisan bill, narrowly averting the blackout as the midnight deadline looms.
Via
Benzinga
These 5 Stocks Are Setting Up This Buying Opportunity After Strong Runs
September 30, 2023
Stocks can offer a new buying opportunity with a pullback to the 50-day line.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2023
Via
Benzinga
Why Shares of Structure Therapeutics Are Soaring on Friday
September 29, 2023
The company reported positive results from an early-stage clinical trial for its weight-loss therapy candidate.
Via
The Motley Fool
Newcomer Structure Throws Down The Gauntlet In Obesity Treatment -- Shares Soar 66%
September 29, 2023
The company is working on a pill to help weight loss, rivaling shots from Novo and, possibly, Lilly.
Via
Investor's Business Daily
Eli Lilly, Former Employee Settle Lawsuit Concerning Manufacturing Dispute
September 29, 2023
Eli Lilly And Co (NYSE: LLY) has settled a lawsuit filed by a former employee, Amrit Mula, who alleged that she was wrongfully terminated after raising concerns about manufacturing practices and data...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle
September 28, 2023
Abbott and Dexcom stocks have tumbled as GLP-1 drugs have gripped the nation.
Via
Investor's Business Daily
After Achieving 100% Cancer Remission Rates In Preclinical Studies, Starpax Magnetodrones Head For Human Trials
September 28, 2023
--News Direct--
Via
News Direct
Topics
Death
Exposures
Death
3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals
September 28, 2023
The demand for biotech stocks is intense and is likely to only greatly increase going forward, especially in the United States.
Via
InvestorPlace
Despite Being Costly, Ozempic, Wegovy Prescriptions Surge 300% Over Three Years
September 28, 2023
An analytics firm Trilliant Health analysis revealed a significant surge in prescriptions for diabetes and obesity drugs like Ozempic and Wegovy during the
Via
Benzinga
Diabetes Prevalence Continues To Rise – Better Therapeutics' Digital Treatment Could Help Change This Trajectory
September 28, 2023
With the ever-increasing prevalence and staggering economic burden, the demand for innovative solutions to treat diabetes has never been higher
Via
Benzinga
Popular Weight Loss Drugs Ozempic and Wegovy Alert: FDA Adds Intestinal Blockage Warning
September 27, 2023
In a significant development, the FDA has updated the labeling for Novo Nordisk A/S's (NYSE: NVO) Ozempic, a diabetes drug known for its weight loss side effect, to include warnings about reports of...
Via
Benzinga
Exposures
Product Safety
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million people worldwide succumb to infections caused...
Via
Benzinga
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications, European Medicines Agency To Investigate
September 27, 2023
The European Medicines Agency (EMA) is set to address concerns related to patients taking drugs such as Novo Nordisk A/S's (NYSE
Via
Benzinga
Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva
September 27, 2023
A federal judge in Massachusetts has overturned a $176.5 million jury verdict against Eli Lilly And Co (NYSE: LLY). T
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Three Of Our Top Picks For Your Healthcare Portfolio
September 26, 2023
Amidst macro uncertainty, healthcare stocks should outperform.
Via
Talk Markets
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
September 26, 2023
With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio.
Via
InvestorPlace
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
76
77
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.